BioCentury

10:09 PM GMT, Nov 28, 2018
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Critics continue to pile on as CRISPR researcher describes informed consent, review process

Jiankui He outlined the peer review and informed consent process used in the first-ever human CRISPR germline gene editing trial at the International Summit on Human Genome Editing on Wednesday. However, critics decried the process as irresponsible and opaque, while a consensus statement from the research community on next steps

Read the full 505 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.